Picture of Porvair logo

PRV Porvair News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapHigh Flyer

REG - Porvair PLC - Trading update and notice of results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241210:nRSJ4137Pa&default-theme=true

RNS Number : 4137P  Porvair PLC  10 December 2024

FOR IMMEDIATE
RELEASE
   10 December 2024

 

 

Porvair plc

("Porvair", the "Group" or the "Company")

 

Trading update for the year ended 30 November 2024 and notice of results

Pre-close trading update

The Group expects revenue growth to be around 9% (13% at constant currency),
with adjusted earnings per share marginally ahead of market expectations.
Net cash at 30 November 2024 was approximately £14 million.

As previously announced, Hooman Caman Javvi will join the Group on 6 January
2025 as Chief Executive Officer designate and Director of the Company.  He
will succeed Ben Stocks following his retirement at the Company's AGM on 15
April 2025.

Notice of results

Porvair will announce its results for the year ended 30 November 2024 on
Monday 10 February 2025.

For further information please contact:

 Porvair plc                                       +44(0)1553 765 500
 Ben Stocks, Group Chief Executive

 James Mills, Group Finance Director

 Burson Buchanan                                   +44(0)20 7466 5000
 Charles Ryland / Stephanie Whitmore / Jack Devoy

 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental
technology businesses.  Its businesses design and manufacture a range of
bespoke consumable filtration products that are used in a range of niche
filtration markets.  It operates in three divisions: Aerospace &
Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFZMGZMLKGDZZ

Recent news on Porvair

See all news